• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On APTCF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Advanced Proteome Therapeutics Corporation (APTCF)

    -Other OTC
    0.15 0.00(0.00%) Nov 26, 11:00AM EST
    Add to Portfolio
    Prev Close:0.15
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.15 - 0.15
    52wk Range:0.14 - 0.35
    Volume:0
    Avg Vol (3m):517
    Market Cap:16.28M
    P/E (ttm):N/A
    EPS (ttm):-0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for APTCF at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company. It focuses on the development of a patent-pending technology that combines multiple anti-cancer therapies... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback